Life sciences

— Pilot Study Paves the Way for Larger Trials on Brain Health Assessment PHILADELPHIA -- In a preliminary investigation, intermittent calorie restriction improved executive function and memory in older adults without cognitive impairments. This 8-week randomized study involved 40 overweight, cognitively healthy seniors with insulin resistance. Researchers compared two dietary strategies: a 5:2 intermittent fasting approach versus a “healthy living” diet, which followed USDA guidelines on

UC Berkeley Engineers Develop Earbuds that Track Brain Signals Linked to Relaxation and Drowsiness Feeling sleepy during work is a common experience, especially after lunch. However, for individuals in high-risk jobs, like driving or operating heavy machinery, drowsiness can be perilous or even fatal. Drowsy driving alone contributes to hundreds of fatal traffic accidents every year across the U.S., and the National Safety Council has highlighted drowsiness as a critical risk in industries like

The United Nations has announced that it will end the employment of nine employees affiliated with the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). This decision comes after an inquiry revealed possible connections between these individuals and Hamas-led attacks on Israel that took place on October 7. The investigation, led by the UN Office of Internal Oversight Services (OIOS), was initiated after accusations surfaced from Israel last year, alleging

— Update from Lancet Commission incorporates vision loss, high LDL to risk factors PHILADELPHIA -- The Lancet Commission on dementia prevention, intervention, and care has expanded the list of modifiable risk factors linked to cognitive decline to 14, after new research conducted since its previous report in 2020. Vision loss and elevated low-density lipoprotein (LDL) cholesterol have been added to the commission's risk factor list, which previously included 12. This revised 57-page

— Disease Burden Could Worsen, Impacting Quality of Life, Experts Warn According to a recent retrospective cohort study, patients diagnosed with alopecia areata (AA) exhibited a greater prevalence of both autoimmune and psychiatric comorbidities at diagnosis. They were also found to be at an increased risk of developing new comorbidities after diagnosis. At diagnosis, 30.9% of patients with alopecia areata had psychiatric comorbidities compared to 26.8% of control subjects without alopecia